Emergent BioSolutions (EBS) Current Deferred Tax Assets (2010 - 2015)

Emergent BioSolutions' Current Deferred Tax Assets history runs 6 years deep, the most recent figure standing at $1.5 million for Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $1.5 million in Q3 2015; TTM through Sep 2015 was $1.5 million, a N/A change from a year earlier, with the FY2014 full-year figure at $1.7 million, changed N/A from the prior year.
• Current Deferred Tax Assets was little changed at $1.5 million in Q3 2015 per EBS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $7.2 million in Q3 2011 and bottomed at $327000.0 in Q3 2012.
• The 5-year median for Current Deferred Tax Assets is $1.4 million (2012), against an average of $2.1 million.
• Across the five-year window, Current Deferred Tax Assets plunged 95.46% in 2012 and soared 286.54% in 2013, its largest moves.
• Year by year, Current Deferred Tax Assets stood at $1.7 million in 2011, then slipped by 27.15% to $1.3 million in 2012, then changed by 0.0% to $1.3 million in 2013, then surged by 35.28% to $1.7 million in 2014, then dropped by 13.27% to $1.5 million in 2015.
• Per Business Quant, the three latest EBS Current Deferred Tax Assets figures stand at $1.5 million (Q3 2015), $1.5 million (Q2 2015), and $1.7 million (Q1 2015).